Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Jnj crawled date : 2021 - 08 - 19 save search
Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022
Published: 2021-08-19 (Crawled : 23:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
HES | $159.13 1.4% 0.0% 2.3M
|
Energy Minerals
|
| O: -2.46%
H: 1.49%
C: 0.7%
Global Antifungal Drug Market Report 2021: Presence of Counterfeit Drugs and Resistance Toward Antifungal Drugs a Major Market Challenge - Forecast to 2026
Published: 2021-08-19 (Crawled : 22:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.56%
H: 0.87%
C: 0.7%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
ABT | News | $106.9 -0.64% 0.0% 5.1M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 1.2M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
drug
Global Antibacterial Markets Report 2021-2026: Focus on B-lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, Phenicols
Published: 2021-08-19 (Crawled : 19:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.17%
H: 0.67%
C: 0.26%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 1.2M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
ITRM | $1.52 -3.8% -3.95% 36K
|
Health Technology
|
| O: 0.28%
H: 3.05%
C: 2.09%
As Delta Variant Surges, More Biopharma Companies Mandate COVID-19 Vaccines
Published: 2021-08-19 (Crawled : 18:00) - biospace.com/
WAT | $310.15 -1.01% 0.0% 530K
|
Health Technology
|
| O: -0.91%
H: 2.86%
C: 1.95%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
covid biopharma vaccine covid-19
Kryon 'Automation Expedition' Global Summit Explores How Process Discovery and RPA Helps Businesses Reach New Heights
Published: 2021-08-19 (Crawled : 16:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
Global Antibiotics Market Report 2021-2026 Featuring Abbott Laboratories, Akron, Amneal Pharmaceuticals, Astellas Pharma, Bausch Health Companies, & Bayer
Published: 2021-08-19 (Crawled : 15:15) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.88%
H: 2.14%
C: 1.6%
BMY | $48.86 -0.27% 0.0% 16M
|
Health Technology
|
| O: -0.41%
H: 2.16%
C: 1.27%
ABT | News | $106.9 -0.64% 0.0% 5.1M
|
Health Technology
|
| O: -0.17%
H: 2.16%
C: 1.62%
SNY | News | $46.765 -1.94% 1.2M
|
Health Technology
|
| O: -0.44%
H: 0.95%
C: 0.15%
antibiotics iot pharma
COVID-19 Boosters Get Official Guidance, Critics Sound Dissent
Published: 2021-08-19 (Crawled : 15:15) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
covid covid-19
Global Intranasal Drug Delivery Market Forecast to 2027: Burgeoning Geriatric Populace Spurs Growing Demand
Published: 2021-08-19 (Crawled : 15:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.54%
H: 0.58%
C: 0.29%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -1.04%
H: 0.8%
C: 0.24%
ATR | $140.22 0.34% 350K
|
Process Industries
|
| O: -0.46%
H: 1.15%
C: 0.74%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.54%
H: 1.13%
C: 0.12%
growing drug drug delivery liver
Avicanna Announces Closing of Secured Debt Financing
Published: 2021-08-19 (Crawled : 15:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
Janssen Presents Phase 1 Results for RYBREVANT™ (amivantamab-vmjw) in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations
Published: 2021-08-19 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
treatment lung cancer phase 1 results cancer
Green Hygienics Holdings Inc. (GRYN) Recruits Former Johnson & Johnson Head of Regulatory & Medical Affairs, Italy, as New Chief Scientific Officer
Published: 2021-08-19 (Crawled : 05:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.32%
H: 1.53%
C: 1.1%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
ILAG | $0.51 6.03% 29.06% 430K
|
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.755 36.99% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.